{"SPADE_N_13610": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_13610", "Peptide Name": "IL-26 (interleukin 26, kinocidin, antimicrobial protein; natural AMPs; humans; primates, mammals, animals; 3S=S, UCSS1a)", "Source": "Th17 cells,Homo sapiens", "Family": "Not found", "Gene": "Not found", "Sequence": "MLVNFILRCGLLLVTLSLAIAKHKQSSFTKSCYPRGTLSQAVDALYIKAAWLKATIPEDRIKNIRLLKKKTKKQFMKNCQFQEQLLSFFMEDVFGQLQLQGCKKIRFVEDFHSLRQKLSHCISCASSAREMKSITRMKRIFYRIGNKGIYKAISELDILLSWIKKLLESSQ", "Sequence Length": 171, "UniProt Entry": "Ref", "Protein Existence": "Not found", "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Antifungal", "Antifungal", "Anti-MRSA"], "Target Organism": "Not found", "Hemolytic Activity": "Not found", "Cytotoxicity": "Not found", "Binding Target": "Not found", "Linear/Cyclic": "Not found", "N-terminal Modification": "Not found", "C-terminal Modification": "Not found", "Stereochemistry": "Not found", "Structure Description": "Not found", "Formula": "Not found", "Mass": 19842.48, "PI": 10.0, "Hydrophobicity": -0.08, "Half Life": "Not found", "Function": "Not found", "Literature": [{"Author": "Weiss DI, Ma F, Merleev AA, Maverakis E, Gilliet M, Balin SJ, Bryson BD, Ochoa MT, Pellegrini M, Bloom BR, Modlin RL.2019", "Reference": "J Immunol. 2019 Jun 24. pii: ji1900318. doi: 10.4049/jimmunol.1900318.PubMed", "Title": "IL-1beta Induces the Rapid Secretion of the Antimicrobial Protein IL-26 from Th17 Cells"}], "Frequent Amino Acids": "LKS", "Absent Amino Acids": "OU", "Basic Residues": 34, "Acidic Residues": 12, "Hydrophobic Residues": 76, "Polar Residues": 96, "Positive Residues": 34, "Negative Residues": 12, "Net Charge": 22, "Comments": "Sequence analysis: APD analysis reveals that the sequence of the peptide shows 14.5% similarity tosPLA2-IIA. This human antimicrobial protein is induced and secreted from Th17 cells by IL-1beta.Activity:  Supernatants from IL-1beta-treated memory T cells killed E. coli in an IL-26-dependent manner. Kills  a vancomycin-resistant clinical isolate of E. faecalis (VRE, 1 h incubation, 99.6% reduction in CFU at 50 ug/ml), S. aureus ATCC 6538 (94.6% CFU reduction at 50 ug/ml after 1h), MRSA, A. baumannii ATCC 19606 (99.8% at 50 ug/ml in 4h), and C. albicans (78.5% reduction at 50 ug/ml in 4 h) (Hansen et al., 2021). Updated 7/2021", "Similar Sequences": []}}}